Investing in
Biotech Innovation
At MintPharma Capital, we are passionate about investing in biotech innovation. We believe in the transformative power of life-changing therapeutics and are committed to supporting dynamic companies at the forefront of this field.
Investing in biotech innovation can be challenging, but we have the expertise and experience to navigate this complex environment. Our team of experts includes seasoned professionals with deep expertise in biotech, previous CEOs and executives of multiple top tier pharmaceutical companies, politicians and regulatory experts who bring a wealth of knowledge and insights to our investment decisions.
What We Look For
Investment Criteria
- Typical Investment
- $2–5 million
- Seed or Series A
- We often act as the lead investor in seed or Series A rounds.
- Development Stage
- We focus on very late-stage pre-clinical and early-stage clinical biotech and pharmaceutical companies, where successful outcomes can create significant value.
- First-in-Class
- We look for new or first-in-class therapies in areas where no FDA-approved treatment currently exists.
- Market Opportunity
- We prefer large commercial markets with significant unmet need and limited existing treatment options.
- Healthcare Economics
- We look for opportunities to improve patients’ lives while reducing the overall financial burden on patients and insurers.